ATTR-CM is a rare, progressive heart disease called transthyretin amyloid cardiomyopathy , where an unstable blood protein (transthyretin) misfolds and builds up in the heart muscle, making it stiff and leading to heart failure–type symptoms over time.

What “ATTR-CM” Means

  • A = Amyloid : Abnormal protein deposits (amyloid) forming in tissues.
  • TTR = Transthyretin : A normal protein made mainly in the liver that carries vitamin A and thyroid hormone but can become unstable.
  • CM = Cardiomyopathy : Disease of the heart muscle that affects how well the heart pumps.

Put together, ATTR-CM is a condition where misfolded transthyretin forms amyloid deposits in the heart, making the walls thick and stiff and reducing pumping efficiency.

Key Facts in Plain Language

  • It is underdiagnosed and potentially fatal if not recognized and managed.
  • The heart often looks thickened but weak, leading to symptoms similar to other heart failure conditions (breathlessness, leg swelling, fatigue).
  • There are two main types :
    • Hereditary ATTR-CM (hATTR-CM) – caused by mutations in the transthyretin gene, runs in families, often shows up from about age 50–60.
* **Wild-type ATTR-CM (wATTR-CM)** – not inherited, occurs without a gene variant, typically in older adults, especially men.

Common Symptoms People Notice

These often mimic “ordinary” heart failure, which is why ATTR-CM can be missed for years:

  • Shortness of breath, especially with activity or when lying flat
  • Fatigue and reduced exercise tolerance
  • Swelling in legs, ankles, or abdomen
  • Irregular heartbeat or atrial fibrillation

There are also “red flag” clues that can show up years before clear heart problems:

  • Carpal tunnel syndrome (often in both wrists)
  • Numbness or tingling in hands and feet (peripheral neuropathy)
  • Unexplained weight loss, digestive issues, or heat intolerance

Why ATTR-CM Is in the News Lately

  • It’s increasingly recognized as an important cause of heart failure in older adults , especially those with thickened heart walls but “normal” pumping strength on echo.
  • Recent articles and patient stories (including from amyloidosis-specific communities and heart organizations) in 2025–2026 emphasize early diagnosis and targeted treatments as new therapies and awareness campaigns roll out.
  • Specialist centers now use advanced scans, biopsies, and genetic testing to distinguish ATTR-CM from other amyloidosis types and tailor therapy.

Tiny FAQ-Style Snapshot

  • Is it genetic?
    • Sometimes yes (hereditary form), sometimes no (wild-type form).
  • Is it curable?
    • It is generally considered chronic and progressive, but disease-modifying treatments can slow progression and improve outcomes if started early.
  • Who should worry about it?
    • Older adults with unexplained thickened heart muscle, heart failure symptoms, plus things like bilateral carpal tunnel or unexplained neuropathy should ask their cardiologist about ATTR-CM.

Information gathered from public forums or data available on the internet and portrayed here.